Mergers & Acquisitions
Mergers & Acquisitions at MONOGRAPH PHARMA
- MONOGRAPH PHARMA provides unmatched expertise throughout the transaction support services life-cycle – from initial target acquisition screening through post-acquisition integration support.
- We identify the true value of an opportunity by combining our meticulous financial analysis with the industry knowledge required to understand how the shifting market landscape can impact potential deals.
- Our experts provide the local insight and skills required to orchestrate complex multinational M&A transactions.
- In the wake of declining revenues, patent expiries, restructuring, strategic shifts and the ever changing industry landscape, Pharma companies need to expand beyond their core business and seek additional revenue streams as well as divest some of the assets.
- MONOGRAPH PHARMA orchestrates divestiture deals against challenging timetables while providing guidance during every phase of the process. We are experts in pharmaceutical divestments, with an impressive record of successful divestment transactions for many of our clients.
Why Choose MONOGRAPH PHARMA for Mergers & Acquisitions?
- Expertise Across the Transaction Life-Cycle: From screening and evaluation to integration, we offer end-to-end support.
- Industry Knowledge: Our deep understanding of the pharmaceutical sector enhances our ability to assess and execute successful deals.
- Local Insight for Global Transactions: Providing the expertise needed for complex multinational transactions.
- Proven Track Record: Demonstrated success in orchestrating both acquisitions and divestments.
Regulatory Due Diligence
Before you move forward with a merger and acquisition (M&A) deal, you need to have a clear understanding of the associated benefits and risks. Our expertise gives us unique insight as we critically evaluate a target company’s characteristics to ensure a good fit for your business. We offer M&A and due diligence solutions including:
